The U.S. Food and Drug Administration approved VEPPANU (vepdegestrant) for treating adults with estrogen receptor-positive, human epidermal growth factor receptor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE